<SEC-DOCUMENT>0000950170-24-046199-index.html : 20240422
<SEC-HEADER>0000950170-24-046199.hdr.sgml : 20240422
<ACCEPTANCE-DATETIME>20240422082347
ACCESSION NUMBER:		0000950170-24-046199
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20240422
DATE AS OF CHANGE:		20240422

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lexeo Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001907108
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				854012572
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-278566
		FILM NUMBER:		24859564

	BUSINESS ADDRESS:	
		STREET 1:		345 PARK AVENUE SOUTH
		STREET 2:		FLOOR 6
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10010
		BUSINESS PHONE:		(212) 547-9879

	MAIL ADDRESS:	
		STREET 1:		345 PARK AVENUE SOUTH
		STREET 2:		FLOOR 6
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10010
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>lxeo_424b3_4-22_bd.htm
<DESCRIPTION>424B3
<TEXT>
Document 1 - file: lxeo_424b3_4-22_bd.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>img228770375_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 2 - file: img228770375_0.jpg

</DOCUMENT>
</SEC-DOCUMENT>